Your browser doesn't support javascript.
loading
TAT-BoNT/A(1₋448), a novel fusion protein as a therapeutic agent: analysis of transcutaneous delivery and enzyme activity.
Saffarian, Parvaneh; Peerayeh, Shahin Najar; Amani, Jafar; Ebrahimi, Firooz; Sedighian, Hamid; Halabian, Raheleh; Fooladi, Abbas Ali Imani.
Afiliação
  • Saffarian P; Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Peerayeh SN; Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. najarp_s@modares.ac.ir.
  • Amani J; Applied Microbiology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Ebrahimi F; Department of Biology, Faculty of Basic Sciences, Imam Hussein University, Tehran, Iran.
  • Sedighian H; Applied Microbiology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Halabian R; Applied Microbiology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Fooladi AA; Applied Microbiology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. imanifouladi.a@gmail.com.
Appl Microbiol Biotechnol ; 100(6): 2785-95, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26711279
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Toxinas Botulínicas Tipo A / Anticonvulsivantes Limite: Animals / Humans Idioma: En Revista: Appl Microbiol Biotechnol Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Toxinas Botulínicas Tipo A / Anticonvulsivantes Limite: Animals / Humans Idioma: En Revista: Appl Microbiol Biotechnol Ano de publicação: 2016 Tipo de documento: Article